These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Striking difference in antiproliferative activity of ruthenium- and osmium-nitrosyl complexes with azole heterocycles. Büchel GE; Gavriluta A; Novak M; Meier SM; Jakupec MA; Cuzan O; Turta C; Tommasino JB; Jeanneau E; Novitchi G; Luneau D; Arion VB Inorg Chem; 2013 Jun; 52(11):6273-85. PubMed ID: 23659478 [TBL] [Abstract][Full Text] [Related]
5. CF3 Derivatives of the Anticancer Ru(III) Complexes KP1019, NKP-1339, and Their Imidazole and Pyridine Analogues Show Enhanced Lipophilicity, Albumin Interactions, and Cytotoxicity. Chang SW; Lewis AR; Prosser KE; Thompson JR; Gladkikh M; Bally MB; Warren JJ; Walsby CJ Inorg Chem; 2016 May; 55(10):4850-63. PubMed ID: 27143338 [TBL] [Abstract][Full Text] [Related]
6. Osmium(IV) complexes with 1H- and 2H-indazoles: tautomer identity versus spectroscopic properties and antiproliferative activity. Büchel GE; Stepanenko IN; Hejl M; Jakupec MA; Keppler BK; Heffeter P; Berger W; Arion VB J Inorg Biochem; 2012 Aug; 113():47-54. PubMed ID: 22687494 [TBL] [Abstract][Full Text] [Related]
8. Mechanism elucidation of the cis-trans isomerization of an azole ruthenium-nitrosyl complex and its osmium counterpart. Gavriluta A; Büchel GE; Freitag L; Novitchi G; Tommasino JB; Jeanneau E; Kuhn PS; González L; Arion VB; Luneau D Inorg Chem; 2013 Jun; 52(11):6260-72. PubMed ID: 23675748 [TBL] [Abstract][Full Text] [Related]
9. Increasing the bioavailability of Ru(III) anticancer complexes through hydrophobic albumin interactions. Webb MI; Wu B; Jang T; Chard RA; Wong EW; Wong MQ; Yapp DT; Walsby CJ Chemistry; 2013 Dec; 19(50):17031-42. PubMed ID: 24203647 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and reactivity of the aquation product of the antitumor complex trans-[Ru(III)Cl4(indazole)2]-. Cebrián-Losantos B; Reisner E; Kowol CR; Roller A; Shova S; Arion VB; Keppler BK Inorg Chem; 2008 Jul; 47(14):6513-23. PubMed ID: 18553904 [TBL] [Abstract][Full Text] [Related]
11. Investigation of the binding of cis/trans-[MCl4(1H-indazole)(NO)](-) (M = Ru, Os) complexes to human serum albumin. Dömötör O; Rathgeb A; Kuhn PS; Popović-Bijelić A; Bačić G; Enyedy EA; Arion VB J Inorg Biochem; 2016 Jun; 159():37-44. PubMed ID: 26908285 [TBL] [Abstract][Full Text] [Related]
12. Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties. Battistin F; Scaletti F; Balducci G; Pillozzi S; Arcangeli A; Messori L; Alessio E J Inorg Biochem; 2016 Jul; 160():180-8. PubMed ID: 26920229 [TBL] [Abstract][Full Text] [Related]
13. Electronic structures of ruthenium and osmium complexes of 9,10-phenanthrenequinone. Biswas MK; Patra SC; Maity AN; Ke SC; Adhikary ND; Ghosh P Inorg Chem; 2012 Jun; 51(12):6687-99. PubMed ID: 22663598 [TBL] [Abstract][Full Text] [Related]
14. Biological properties of novel ruthenium- and osmium-nitrosyl complexes with azole heterocycles. Novak MS; Büchel GE; Keppler BK; Jakupec MA J Biol Inorg Chem; 2016 Jun; 21(3):347-56. PubMed ID: 26961253 [TBL] [Abstract][Full Text] [Related]
15. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes. van Rijt SH; Hebden AJ; Amaresekera T; Deeth RJ; Clarkson GJ; Parsons S; McGowan PC; Sadler PJ J Med Chem; 2009 Dec; 52(23):7753-64. PubMed ID: 19791745 [TBL] [Abstract][Full Text] [Related]